Selected research
Industry Research
Biomanufacturing in Bio-based Materials Industry Research Report 2026
Market perspective
The global Biomanufacturing in Bio-based Materials market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biomanufacturing in Bio-based Materials market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biomanufacturing in Bio-based Materials market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biomanufacturing in Bio-based Materials market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biomanufacturing in Bio-based Materials include Braskem, NatureWorks, Tate & Lyle, Fufeng Group, Meihua Group, Bloomage Biotech, Anhui BBCA Group, Lushang Freda and Total Corbion, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biomanufacturing in Bio-based Materials market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomanufacturing in Bio-based Materials.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomanufacturing in Bio-based Materials Market by Company
Braskem
NatureWorks
Tate & Lyle
Fufeng Group
Meihua Group
Bloomage Biotech
Anhui BBCA Group
Lushang Freda
Total Corbion
Zhejiang Hisun Biomaterials
Pharmacosmos A/S
Danimer Scientific
Kingfa Sci.&Tech
Kewpie Corporation
Vedan Biotechnology
Giant Biogene
Contipro Inc.
Shandong Topscience Biotech
Blue Ridge Tunhe
JNC Corporation
NAGASE
CJ Bio
Bluepha
Givaudan
RWDC Industries
Toyobo
PTT MCC Biochem
TianAn Biologic Materials Co
Kaneka
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
Cathay Biotech Inc.
Zhejiang Shengda Bio-Pharm
DANCHENG CAIXIN SUGAR INDUSTRY
CanSinoBIO
AMSilk GmbH
Shandong AWA Biopharm
Shandong Mimei Biotechnology
Juyou Bio-Technology
Shanghai Techwell Biopharmacieutical
Jinpu Nuoan Biotechnology
Jinyang Pharmaceutical
Ningxia Eppen Biotech
Kuraray
Shanxi Jinbo Bio-pharmaceutical
Wuhu Interferon
Evonik
TS-Biotech
Nanjing XuanKai Biotechnology
HTL Biotechnology
Biomanufacturing in Bio-based Materials Segment by Type
Polysaccharide Polymers
Protein Polymers
Polyester Polymers
Others
Biomanufacturing in Bio-based Materials Segment by Application
Food & Beverage
Daily Chemicals
Medical
Packaging
Textiles
Automotive Industry
Other
Biomanufacturing in Bio-based Materials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomanufacturing in Bio-based Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomanufacturing in Bio-based Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomanufacturing in Bio-based Materials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomanufacturing in Bio-based Materials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polysaccharide Polymers
- Protein Polymers
- Polyester Polymers
- Others
Applications
- Food & Beverage
- Daily Chemicals
- Medical
- Packaging
- Textiles
- Automotive Industry
- Other
Companies covered
- Braskem
- NatureWorks
- Tate & Lyle
- Fufeng Group
- Meihua Group
- Bloomage Biotech
- Anhui BBCA Group
- Lushang Freda
- Total Corbion
- Zhejiang Hisun Biomaterials
- Pharmacosmos A/S
- Danimer Scientific
- Kingfa Sci.&Tech
- Kewpie Corporation
- Vedan Biotechnology
- Giant Biogene
- Contipro Inc.
- Shandong Topscience Biotech
- Blue Ridge Tunhe
- JNC Corporation
- NAGASE
- CJ Bio
- Bluepha
- Givaudan
- RWDC Industries
- Toyobo
- PTT MCC Biochem
- TianAn Biologic Materials Co
- Kaneka
- Jiangsu JLand Biotech
- Jiangsu Chuangjian Medical Technology
- Cathay Biotech Inc.
- Zhejiang Shengda Bio-Pharm
- DANCHENG CAIXIN SUGAR INDUSTRY
- CanSinoBIO
- AMSilk GmbH
- Shandong AWA Biopharm
- Shandong Mimei Biotechnology
- Juyou Bio-Technology
- Shanghai Techwell Biopharmacieutical
- Jinpu Nuoan Biotechnology
- Jinyang Pharmaceutical
- Ningxia Eppen Biotech
- Kuraray
- Shanxi Jinbo Bio-pharmaceutical
- Wuhu Interferon
- Evonik
- TS-Biotech
- Nanjing XuanKai Biotechnology
- HTL Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomanufacturing in Bio-based Materials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Polysaccharide Polymers
- 2.2.3 Protein Polymers
- 2.2.4 Polyester Polymers
- 2.2.5 Others
- 2.3 Biomanufacturing in Bio-based Materials by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Food & Beverage
- 2.3.3 Daily Chemicals
- 2.3.4 Medical
- 2.3.5 Packaging
- 2.3.6 Textiles
- 2.3.7 Automotive Industry
- 2.3.8 Other
- 2.4 Assumptions and Limitations
3 Biomanufacturing in Bio-based Materials Breakdown Data by Type
- 3.1 Global Biomanufacturing in Bio-based Materials Historic Market Size by Type (2021-2026)
- 3.2 Global Biomanufacturing in Bio-based Materials Forecasted Market Size by Type (2027-2032)
4 Biomanufacturing in Bio-based Materials Breakdown Data by Application
- 4.1 Global Biomanufacturing in Bio-based Materials Historic Market Size by Application (2021-2026)
- 4.2 Global Biomanufacturing in Bio-based Materials Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomanufacturing in Bio-based Materials Market Perspective (2021-2032)
- 5.2 Global Biomanufacturing in Bio-based Materials Growth Trends by Region
- 5.2.1 Global Biomanufacturing in Bio-based Materials Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomanufacturing in Bio-based Materials Historic Market Size by Region (2021-2026)
- 5.2.3 Biomanufacturing in Bio-based Materials Forecasted Market Size by Region (2027-2032)
- 5.3 Biomanufacturing in Bio-based Materials Market Dynamics
- 5.3.1 Biomanufacturing in Bio-based Materials Industry Trends
- 5.3.2 Biomanufacturing in Bio-based Materials Market Drivers
- 5.3.3 Biomanufacturing in Bio-based Materials Market Challenges
- 5.3.4 Biomanufacturing in Bio-based Materials Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomanufacturing in Bio-based Materials Players by Revenue
- 6.1.1 Global Top Biomanufacturing in Bio-based Materials Players by Revenue (2021-2026)
- 6.1.2 Global Biomanufacturing in Bio-based Materials Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomanufacturing in Bio-based Materials Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomanufacturing in Bio-based Materials Head Office and Area Served
- 6.4 Global Biomanufacturing in Bio-based Materials Players, Product Type & Application
- 6.5 Global Biomanufacturing in Bio-based Materials Manufacturers Established Date
- 6.6 Global Biomanufacturing in Bio-based Materials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomanufacturing in Bio-based Materials Market Size (2021-2032)
- 7.2 North America Biomanufacturing in Bio-based Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomanufacturing in Bio-based Materials Market Size by Country (2021-2026)
- 7.4 North America Biomanufacturing in Bio-based Materials Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomanufacturing in Bio-based Materials Market Size (2021-2032)
- 8.2 Europe Biomanufacturing in Bio-based Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomanufacturing in Bio-based Materials Market Size by Country (2021-2026)
- 8.4 Europe Biomanufacturing in Bio-based Materials Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomanufacturing in Bio-based Materials Market Size (2021-2032)
- 9.2 Asia-Pacific Biomanufacturing in Bio-based Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomanufacturing in Bio-based Materials Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomanufacturing in Bio-based Materials Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomanufacturing in Bio-based Materials Market Size (2021-2032)
- 10.2 South America Biomanufacturing in Bio-based Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomanufacturing in Bio-based Materials Market Size by Country (2021-2026)
- 10.4 South America Biomanufacturing in Bio-based Materials Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomanufacturing in Bio-based Materials Market Size (2021-2032)
- 11.2 Middle East & Africa Biomanufacturing in Bio-based Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomanufacturing in Bio-based Materials Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomanufacturing in Bio-based Materials Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Braskem
- 12.1.1 Braskem Company Information
- 12.1.2 Braskem Business Overview
- 12.1.3 Braskem Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.1.4 Braskem Biomanufacturing in Bio-based Materials Product Portfolio
- 12.1.5 Braskem Recent Developments
- 12.2 NatureWorks
- 12.2.1 NatureWorks Company Information
- 12.2.2 NatureWorks Business Overview
- 12.2.3 NatureWorks Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.2.4 NatureWorks Biomanufacturing in Bio-based Materials Product Portfolio
- 12.2.5 NatureWorks Recent Developments
- 12.3 Tate & Lyle
- 12.3.1 Tate & Lyle Company Information
- 12.3.2 Tate & Lyle Business Overview
- 12.3.3 Tate & Lyle Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.3.4 Tate & Lyle Biomanufacturing in Bio-based Materials Product Portfolio
- 12.3.5 Tate & Lyle Recent Developments
- 12.4 Fufeng Group
- 12.4.1 Fufeng Group Company Information
- 12.4.2 Fufeng Group Business Overview
- 12.4.3 Fufeng Group Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.4.4 Fufeng Group Biomanufacturing in Bio-based Materials Product Portfolio
- 12.4.5 Fufeng Group Recent Developments
- 12.5 Meihua Group
- 12.5.1 Meihua Group Company Information
- 12.5.2 Meihua Group Business Overview
- 12.5.3 Meihua Group Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.5.4 Meihua Group Biomanufacturing in Bio-based Materials Product Portfolio
- 12.5.5 Meihua Group Recent Developments
- 12.6 Bloomage Biotech
- 12.6.1 Bloomage Biotech Company Information
- 12.6.2 Bloomage Biotech Business Overview
- 12.6.3 Bloomage Biotech Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.6.4 Bloomage Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 12.6.5 Bloomage Biotech Recent Developments
- 12.7 Anhui BBCA Group
- 12.7.1 Anhui BBCA Group Company Information
- 12.7.2 Anhui BBCA Group Business Overview
- 12.7.3 Anhui BBCA Group Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.7.4 Anhui BBCA Group Biomanufacturing in Bio-based Materials Product Portfolio
- 12.7.5 Anhui BBCA Group Recent Developments
- 12.8 Lushang Freda
- 12.8.1 Lushang Freda Company Information
- 12.8.2 Lushang Freda Business Overview
- 12.8.3 Lushang Freda Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.8.4 Lushang Freda Biomanufacturing in Bio-based Materials Product Portfolio
- 12.8.5 Lushang Freda Recent Developments
- 12.9 Total Corbion
- 12.9.1 Total Corbion Company Information
- 12.9.2 Total Corbion Business Overview
- 12.9.3 Total Corbion Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.9.4 Total Corbion Biomanufacturing in Bio-based Materials Product Portfolio
- 12.9.5 Total Corbion Recent Developments
- 12.10 Zhejiang Hisun Biomaterials
- 12.10.1 Zhejiang Hisun Biomaterials Company Information
- 12.10.2 Zhejiang Hisun Biomaterials Business Overview
- 12.10.3 Zhejiang Hisun Biomaterials Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.10.4 Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Product Portfolio
- 12.10.5 Zhejiang Hisun Biomaterials Recent Developments
- 12.11 Pharmacosmos A/S
- 12.11.1 Pharmacosmos A/S Company Information
- 12.11.2 Pharmacosmos A/S Business Overview
- 12.11.3 Pharmacosmos A/S Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.11.4 Pharmacosmos A/S Biomanufacturing in Bio-based Materials Product Portfolio
- 12.11.5 Pharmacosmos A/S Recent Developments
- 12.12 Danimer Scientific
- 12.12.1 Danimer Scientific Company Information
- 12.12.2 Danimer Scientific Business Overview
- 12.12.3 Danimer Scientific Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.12.4 Danimer Scientific Biomanufacturing in Bio-based Materials Product Portfolio
- 12.12.5 Danimer Scientific Recent Developments
- 12.13 Kingfa Sci.&Tech
- 12.13.1 Kingfa Sci.&Tech Company Information
- 12.13.2 Kingfa Sci.&Tech Business Overview
- 12.13.3 Kingfa Sci.&Tech Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.13.4 Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Product Portfolio
- 12.13.5 Kingfa Sci.&Tech Recent Developments
- 12.14 Kewpie Corporation
- 12.14.1 Kewpie Corporation Company Information
- 12.14.2 Kewpie Corporation Business Overview
- 12.14.3 Kewpie Corporation Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.14.4 Kewpie Corporation Biomanufacturing in Bio-based Materials Product Portfolio
- 12.14.5 Kewpie Corporation Recent Developments
- 12.15 Vedan Biotechnology
- 12.15.1 Vedan Biotechnology Company Information
- 12.15.2 Vedan Biotechnology Business Overview
- 12.15.3 Vedan Biotechnology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.15.4 Vedan Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.15.5 Vedan Biotechnology Recent Developments
- 12.16 Giant Biogene
- 12.16.1 Giant Biogene Company Information
- 12.16.2 Giant Biogene Business Overview
- 12.16.3 Giant Biogene Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.16.4 Giant Biogene Biomanufacturing in Bio-based Materials Product Portfolio
- 12.16.5 Giant Biogene Recent Developments
- 12.17 Contipro Inc.
- 12.17.1 Contipro Inc. Company Information
- 12.17.2 Contipro Inc. Business Overview
- 12.17.3 Contipro Inc. Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.17.4 Contipro Inc. Biomanufacturing in Bio-based Materials Product Portfolio
- 12.17.5 Contipro Inc. Recent Developments
- 12.18 Shandong Topscience Biotech
- 12.18.1 Shandong Topscience Biotech Company Information
- 12.18.2 Shandong Topscience Biotech Business Overview
- 12.18.3 Shandong Topscience Biotech Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.18.4 Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 12.18.5 Shandong Topscience Biotech Recent Developments
- 12.19 Blue Ridge Tunhe
- 12.19.1 Blue Ridge Tunhe Company Information
- 12.19.2 Blue Ridge Tunhe Business Overview
- 12.19.3 Blue Ridge Tunhe Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.19.4 Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Product Portfolio
- 12.19.5 Blue Ridge Tunhe Recent Developments
- 12.20 JNC Corporation
- 12.20.1 JNC Corporation Company Information
- 12.20.2 JNC Corporation Business Overview
- 12.20.3 JNC Corporation Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.20.4 JNC Corporation Biomanufacturing in Bio-based Materials Product Portfolio
- 12.20.5 JNC Corporation Recent Developments
- 12.21 NAGASE
- 12.21.1 NAGASE Company Information
- 12.21.2 NAGASE Business Overview
- 12.21.3 NAGASE Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.21.4 NAGASE Biomanufacturing in Bio-based Materials Product Portfolio
- 12.21.5 NAGASE Recent Developments
- 12.22 CJ Bio
- 12.22.1 CJ Bio Company Information
- 12.22.2 CJ Bio Business Overview
- 12.22.3 CJ Bio Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.22.4 CJ Bio Biomanufacturing in Bio-based Materials Product Portfolio
- 12.22.5 CJ Bio Recent Developments
- 12.23 Bluepha
- 12.23.1 Bluepha Company Information
- 12.23.2 Bluepha Business Overview
- 12.23.3 Bluepha Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.23.4 Bluepha Biomanufacturing in Bio-based Materials Product Portfolio
- 12.23.5 Bluepha Recent Developments
- 12.24 Givaudan
- 12.24.1 Givaudan Company Information
- 12.24.2 Givaudan Business Overview
- 12.24.3 Givaudan Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.24.4 Givaudan Biomanufacturing in Bio-based Materials Product Portfolio
- 12.24.5 Givaudan Recent Developments
- 12.25 RWDC Industries
- 12.25.1 RWDC Industries Company Information
- 12.25.2 RWDC Industries Business Overview
- 12.25.3 RWDC Industries Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.25.4 RWDC Industries Biomanufacturing in Bio-based Materials Product Portfolio
- 12.25.5 RWDC Industries Recent Developments
- 12.26 Toyobo
- 12.26.1 Toyobo Company Information
- 12.26.2 Toyobo Business Overview
- 12.26.3 Toyobo Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.26.4 Toyobo Biomanufacturing in Bio-based Materials Product Portfolio
- 12.26.5 Toyobo Recent Developments
- 12.27 PTT MCC Biochem
- 12.27.1 PTT MCC Biochem Company Information
- 12.27.2 PTT MCC Biochem Business Overview
- 12.27.3 PTT MCC Biochem Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.27.4 PTT MCC Biochem Biomanufacturing in Bio-based Materials Product Portfolio
- 12.27.5 PTT MCC Biochem Recent Developments
- 12.28 TianAn Biologic Materials Co
- 12.28.1 TianAn Biologic Materials Co Company Information
- 12.28.2 TianAn Biologic Materials Co Business Overview
- 12.28.3 TianAn Biologic Materials Co Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.28.4 TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Product Portfolio
- 12.28.5 TianAn Biologic Materials Co Recent Developments
- 12.29 Kaneka
- 12.29.1 Kaneka Company Information
- 12.29.2 Kaneka Business Overview
- 12.29.3 Kaneka Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.29.4 Kaneka Biomanufacturing in Bio-based Materials Product Portfolio
- 12.29.5 Kaneka Recent Developments
- 12.30 Jiangsu JLand Biotech
- 12.30.1 Jiangsu JLand Biotech Company Information
- 12.30.2 Jiangsu JLand Biotech Business Overview
- 12.30.3 Jiangsu JLand Biotech Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.30.4 Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 12.30.5 Jiangsu JLand Biotech Recent Developments
- 12.31 Jiangsu Chuangjian Medical Technology
- 12.31.1 Jiangsu Chuangjian Medical Technology Company Information
- 12.31.2 Jiangsu Chuangjian Medical Technology Business Overview
- 12.31.3 Jiangsu Chuangjian Medical Technology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.31.4 Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.31.5 Jiangsu Chuangjian Medical Technology Recent Developments
- 12.32 Cathay Biotech Inc.
- 12.32.1 Cathay Biotech Inc. Company Information
- 12.32.2 Cathay Biotech Inc. Business Overview
- 12.32.3 Cathay Biotech Inc. Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.32.4 Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Product Portfolio
- 12.32.5 Cathay Biotech Inc. Recent Developments
- 12.33 Zhejiang Shengda Bio-Pharm
- 12.33.1 Zhejiang Shengda Bio-Pharm Company Information
- 12.33.2 Zhejiang Shengda Bio-Pharm Business Overview
- 12.33.3 Zhejiang Shengda Bio-Pharm Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.33.4 Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Product Portfolio
- 12.33.5 Zhejiang Shengda Bio-Pharm Recent Developments
- 12.34 DANCHENG CAIXIN SUGAR INDUSTRY
- 12.34.1 DANCHENG CAIXIN SUGAR INDUSTRY Company Information
- 12.34.2 DANCHENG CAIXIN SUGAR INDUSTRY Business Overview
- 12.34.3 DANCHENG CAIXIN SUGAR INDUSTRY Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.34.4 DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Product Portfolio
- 12.34.5 DANCHENG CAIXIN SUGAR INDUSTRY Recent Developments
- 12.35 CanSinoBIO
- 12.35.1 CanSinoBIO Company Information
- 12.35.2 CanSinoBIO Business Overview
- 12.35.3 CanSinoBIO Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.35.4 CanSinoBIO Biomanufacturing in Bio-based Materials Product Portfolio
- 12.35.5 CanSinoBIO Recent Developments
- 12.36 AMSilk GmbH
- 12.36.1 AMSilk GmbH Company Information
- 12.36.2 AMSilk GmbH Business Overview
- 12.36.3 AMSilk GmbH Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.36.4 AMSilk GmbH Biomanufacturing in Bio-based Materials Product Portfolio
- 12.36.5 AMSilk GmbH Recent Developments
- 12.37 Shandong AWA Biopharm
- 12.37.1 Shandong AWA Biopharm Company Information
- 12.37.2 Shandong AWA Biopharm Business Overview
- 12.37.3 Shandong AWA Biopharm Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.37.4 Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Product Portfolio
- 12.37.5 Shandong AWA Biopharm Recent Developments
- 12.38 Shandong Mimei Biotechnology
- 12.38.1 Shandong Mimei Biotechnology Company Information
- 12.38.2 Shandong Mimei Biotechnology Business Overview
- 12.38.3 Shandong Mimei Biotechnology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.38.4 Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.38.5 Shandong Mimei Biotechnology Recent Developments
- 12.39 Juyou Bio-Technology
- 12.39.1 Juyou Bio-Technology Company Information
- 12.39.2 Juyou Bio-Technology Business Overview
- 12.39.3 Juyou Bio-Technology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.39.4 Juyou Bio-Technology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.39.5 Juyou Bio-Technology Recent Developments
- 12.40 Shanghai Techwell Biopharmacieutical
- 12.40.1 Shanghai Techwell Biopharmacieutical Company Information
- 12.40.2 Shanghai Techwell Biopharmacieutical Business Overview
- 12.40.3 Shanghai Techwell Biopharmacieutical Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.40.4 Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Product Portfolio
- 12.40.5 Shanghai Techwell Biopharmacieutical Recent Developments
- 12.41 Jinpu Nuoan Biotechnology
- 12.41.1 Jinpu Nuoan Biotechnology Company Information
- 12.41.2 Jinpu Nuoan Biotechnology Business Overview
- 12.41.3 Jinpu Nuoan Biotechnology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.41.4 Jinpu Nuoan Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.41.5 Jinpu Nuoan Biotechnology Recent Developments
- 12.42 Jinyang Pharmaceutical
- 12.42.1 Jinyang Pharmaceutical Company Information
- 12.42.2 Jinyang Pharmaceutical Business Overview
- 12.42.3 Jinyang Pharmaceutical Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.42.4 Jinyang Pharmaceutical Biomanufacturing in Bio-based Materials Product Portfolio
- 12.42.5 Jinyang Pharmaceutical Recent Developments
- 12.43 Ningxia Eppen Biotech
- 12.43.1 Ningxia Eppen Biotech Company Information
- 12.43.2 Ningxia Eppen Biotech Business Overview
- 12.43.3 Ningxia Eppen Biotech Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.43.4 Ningxia Eppen Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 12.43.5 Ningxia Eppen Biotech Recent Developments
- 12.44 Kuraray
- 12.44.1 Kuraray Company Information
- 12.44.2 Kuraray Business Overview
- 12.44.3 Kuraray Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.44.4 Kuraray Biomanufacturing in Bio-based Materials Product Portfolio
- 12.44.5 Kuraray Recent Developments
- 12.45 Shanxi Jinbo Bio-pharmaceutical
- 12.45.1 Shanxi Jinbo Bio-pharmaceutical Company Information
- 12.45.2 Shanxi Jinbo Bio-pharmaceutical Business Overview
- 12.45.3 Shanxi Jinbo Bio-pharmaceutical Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.45.4 Shanxi Jinbo Bio-pharmaceutical Biomanufacturing in Bio-based Materials Product Portfolio
- 12.45.5 Shanxi Jinbo Bio-pharmaceutical Recent Developments
- 12.46 Wuhu Interferon
- 12.46.1 Wuhu Interferon Company Information
- 12.46.2 Wuhu Interferon Business Overview
- 12.46.3 Wuhu Interferon Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.46.4 Wuhu Interferon Biomanufacturing in Bio-based Materials Product Portfolio
- 12.46.5 Wuhu Interferon Recent Developments
- 12.47 Evonik
- 12.47.1 Evonik Company Information
- 12.47.2 Evonik Business Overview
- 12.47.3 Evonik Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.47.4 Evonik Biomanufacturing in Bio-based Materials Product Portfolio
- 12.47.5 Evonik Recent Developments
- 12.48 TS-Biotech
- 12.48.1 TS-Biotech Company Information
- 12.48.2 TS-Biotech Business Overview
- 12.48.3 TS-Biotech Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.48.4 TS-Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 12.48.5 TS-Biotech Recent Developments
- 12.49 Nanjing XuanKai Biotechnology
- 12.49.1 Nanjing XuanKai Biotechnology Company Information
- 12.49.2 Nanjing XuanKai Biotechnology Business Overview
- 12.49.3 Nanjing XuanKai Biotechnology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.49.4 Nanjing XuanKai Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.49.5 Nanjing XuanKai Biotechnology Recent Developments
- 12.50 HTL Biotechnology
- 12.50.1 HTL Biotechnology Company Information
- 12.50.2 HTL Biotechnology Business Overview
- 12.50.3 HTL Biotechnology Revenue in Biomanufacturing in Bio-based Materials Business (2021-2026)
- 12.50.4 HTL Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 12.50.5 HTL Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst